Ann: CVac shows overall survival benefit, page-27

I have watched this stock for nearly 3 years and made my first trade this morning for a small profit within about 10 mins. Condolences to all the LT's here who have had to put up with some very questionable management over the years.

I do have a question for the informed LT holders here, this OS survival data seems to be significantly better than what was published by Provenge? (I know that was a dogs breakfast), but surely this should instigate some big pharma interest. From what I understand, there isn't a lot of other options for this horrible disease & there are manufacturing facilities & processes in place to get this to market should it get approval and funding?